2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)- (36574-15-9)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4S,4aR,5S,5aR,6R,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrate (1:1), (4S,4aR,5S,5aR,6R,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,calcium salt (1:2), (4S,4aR,5S,5aR,6R,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-,(4S,4aR,- 5S,5aR,6S,12aS)-,mixt. with 2-methyl-5-nitro-1H-imidazole-1-ethanol and 3-[[(5-nitro-2-furanyl)methylene]amino]- 2-oxazolidinone
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4R,4aR,5S,5aR,6R,12aS)-
- Estra-1,3,5(10)-triene-3,17-diol (17â)-,esters,3-benzoate,mixt. with 2-(diethylamino)-N-(2,6-dimethylphenyl)- acetamide monohydrochloride and (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4S,4aR,5S,5aR,6S,12aS)-
- Sulfuric acid copper(2+) salt (1:1),compounds,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,calcium salt (1:1), (4S,4aR,5S,5aR,6S,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,calcium salt (2:1), (4S,4aR,5S,5aR,6S,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,hydrate (1:2), (4S,4aR,5S,5aR,6S,12aS)-
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
- 2-Naphthacenecarboxamide,1,4,4a,5,5a,6,11,- 12a-octahydro-3,5,10,12,12a-pentahydroxy-6- methyl-1,11-dioxo-,(4aR,5S,5aR,6R,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6S,12aS)-,mixt. with (1R,2R)-2,2-dichloro-N-[2- hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)- ethyl]acetamide
- Neomycin,sulfate (salt),mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride and 8-quinolinol sulfate (2:1) (salt)
- Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
- Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
- L-Ascorbic acid,compounds,mixt. with 3-[(4-amino-2-methyl-5-pyrimidinyl)- methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride,(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide and riboflavin
- Arsonic acid,(4-aminophenyl)-,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide and 3-[[(5-nitro-2-furanyl)methylene]amino]-2- oxazolidinone